Logiq Sees Q3 2021 Revenue Exceeding $7.7 Million, up ~10%, with Gross Margins Nearly Doubling to More than 29.0%

Written by Customer Service on October 27, 2021. Posted in Public Companies.

NEW YORK, Oct. 27, 2021 (GLOBE NEWSWIRE) — Logiq, Inc. (OTCQX: LGIQ, NEO: LGIQ), a global provider of award-winning consumer acquisition solutions, reported preliminary results for the third quarter ended September 30, 2021. The company expects revenue for the third quarter to exceed $7.7 million, up approximately 10% from the same year-ago quarter. Gross margin is expected to expand to more than 29.0%, nearly doubling from 15.8% in the same year-ago quarter. “Our strong year-over-year performance reflects the continued transformation of our business that is now focused on higher margin, higher quality revenue streams,” stated Brent Suen, president of Logiq. “Over the past year we have also established a stronger foundation for addressing the abundant e-commerce opportunities worldwide.” “We believe the progress we have made, particularly...

CN Board Appoints Jo-ann dePass Olsovsky to its Board of Directors

Written by Customer Service on October 27, 2021. Posted in Public Companies.

Independent Director with Deep Technology and Railroad Experience Demonstrates Board’s Ongoing Commitment to CN’s Leadership in Corporate Governance MONTREAL, Oct. 27, 2021 (GLOBE NEWSWIRE) — CN (TSX: CNR) (NYSE: CNI) announced today that Jo-ann dePass Olsovsky has been appointed to serve on the Board of Directors of CN, effective immediately. Ms. dePass Olsovsky, 56, brings more than 35 years of technology, infrastructure operations, and railroad experience to CN. She is currently the Executive Vice President and Chief Information Officer of Salesforce, where she oversees the company’s global information technology organization, including technology strategy; customer, partner and employee experience; enterprise applications; network infrastructure; collaboration tools; 7×24 enterprise operations; architecture; and merger...

Valley National Bancorp Announces the Receipt of Required Regulatory Approvals for the Acquisition of the Westchester Bank Holding Corporation

Written by Customer Service on October 27, 2021. Posted in Mergers And Acquisitions.

NEW YORK, Oct. 27, 2021 (GLOBE NEWSWIRE) — Valley National Bancorp (NASDAQ:VLY), the holding company for Valley National Bank, (“Valley”) announced that regulatory approvals for the previously announced acquisition of The Westchester Bank Holding Corporation (“Westchester”), and its banking subsidiary The Westchester Bank has been received from the Office of the Comptroller of the Currency, the Board of Governors of the Federal Reserve System and the New York State Department of Financial Services. No further regulatory approvals are required to complete the acquisition and merger of Westchester into Valley. Westchester stockholders had previously approved the merger on October 5, 2021. The acquisition is anticipated to close on December 1, 2021, pending the satisfaction of customary closing conditions. Upon closing, Valley will...

Proactive news headlines including Benchmark Metals, Western Magnesium, Mindset Pharma, CO2 GRO, FansUnite and Love Pharma

Written by Customer Service on October 27, 2021. Posted in Mergers And Acquisitions.

New York , Oct. 27, 2021 (GLOBE NEWSWIRE) — Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies: Benchmark Metals intersects high-grade gold and silver at the Marmot Zone in British Columbia click here Ridgeline Minerals provides updates on its four Nevada-based exploration projects, says Phase II drill at Carlin-East Project completed in October click here Phunware says its mobile Digital Front Door solution for healthcare now available on Epic App Orchard marketplace click here Quaterra Resources awards McClelland Laboratories a key contract to support the advancement of the MacArthur oxide copper project click here Goldseek Resources wraps up 5,000 metre drill program at Beschefer gold project click here BioHarvest Sciences adds Steven...

Sorrento Announces Encouraging Results From Two Phase 2 Studies of Abivertinib For Treatment Of Hospitalized Severe COVID-19 Patients

Written by Customer Service on October 27, 2021. Posted in Public Companies.

Abivertinib is an oral capsule (100 mg QD or two 50-mg capsules a day) that potentially reduces cytokine storm associated with acute respiratory distress syndrome (ARDS) in severe hospitalized COVID-19 patients. Preliminary results from two completed Phase 2 studies: US study (N=96) and Brazil study (N=400) have identified an At-Risk COVID-19 Patient Population – Hospitalized COVID patients receiving oxygen support by non-invasive ventilation or high flow oxygen – which can potentially benefit from Abivertinib treatment. The At-Risk COVID-19 Patients show a reduction (20% reduction in the US study and 25% in the Brazil study, respectively) in death or respiratory failure at one month time point. The At-Risk Patients in the US study (who were a sicker population than those in the Brazilian study) were discharged on average...

Lake Shore Bancorp, Inc. Announces 2021 Third Quarter and Year to Date Financial Results and Declares Dividend

Written by Customer Service on October 27, 2021. Posted in Public Companies.

DUNKIRK, N.Y., Oct. 27, 2021 (GLOBE NEWSWIRE) — Lake Shore Bancorp, Inc. (the “Company”) (NASDAQ: LSBK), the holding company for Lake Shore Savings Bank (the “Bank”), reported unaudited net income of $1.7 million, or $0.29 per diluted share, for the third quarter of 2021 compared to net income of $1.2 million, or $0.21 per diluted share, for the third quarter of 2020. For the first nine months of 2021, the Company reported unaudited net income of $4.4 million, or $0.74 per diluted share, as compared to $3.3 million, or $0.56 per diluted share, for the first nine months of 2020. 2021 Third Quarter and Year to Date Financial Highlights: Net income of $1.7 million in the third quarter of 2021 increased by $460,000, or 37.4%, when compared to the third quarter of 2020. Third quarter 2021 net income was positively impacted by an increase...

Plus Therapeutics Announces Presentation of ReSPECT-GBM Trial Dosimetery Data at the American Society for Radiation Oncology (ASTRO) 2021 Annual Meeting

Written by Customer Service on October 27, 2021. Posted in Public Companies.

Data demonstrated Rhenium-186 NanoLiposome (186RNL) provides sustained, localized radiation treatment for over eight days to the tumor with minimal whole brain and body radiation exposure The analysis of 3D drug distribution and tumor response shows image monitoring is a predictive tool to evaluate delivery and treatment effectiveness Compared to sealed source brachytherapy, 186RNL offers minimally invasive, convenient delivery AUSTIN, Texas, Oct. 27, 2021 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing innovative, targeted radiotherapeutics for rare and difficult-to-treat cancers, today presented data at the American Society for Radiation Oncology (ASTRO) 2021 Annual Meeting indicating Rhenium-186 NanoLiposome (186RNL) delivered to patients with recurrent...

Festi hf.: Changes in management at ELKO

Written by Customer Service on October 27, 2021. Posted in Public Companies.

ELKO Managing Director, Gestur Hjaltason has resigned from his position as of December 31 2021, after successfully leading the company from 2002. ELKO’s board has appointed Deputy Managing Director, Óttar Örn Sigurbergsson, as the new Managing Director of ELKO as of January 1, 2022. Mr Sigurbergsson has worked for the company since 2004 and Mr Hjaltason will be of assistance until the middle of next year. Eggert Þór Kristófersson, CEO of Festi: “I want to thank Mr Hjaltason for great collaboration in the past years. It is safe to say that Mr Hjaltason has had a great and positive impact on ELKO’s operations and success throughout the years as he has diligently managed the company for nearly 20 years. On behalf of ELKO’s board and Festi, I wish Mr Hjaltason the best of luck at this juncture. We are fortunate that Mr Sigurbergsson will...

Mitesco Board of Directors and The Good Clinic™ Executives Share Industry Outlook and the Business Opportunity

Written by Customer Service on October 27, 2021. Posted in Public Companies.

MINNEAPOLIS, MN, Oct. 27, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Mitesco, Inc. (OTCQB: MITI) (“Mitesco” or the “Company”), a leading operator of wellness clinics that combine technology and personalized, whole-person primary care, announced it has developed a series of informational video interviews featuring Mitesco board members and executives on the leadership team at The Good Clinic, LLC, a Mitesco subsidiary. The videos focus on how Mitesco and The Good Clinic are redefining primary care by prioritizing the patient’s needs, making healthcare more accessible, and leveraging technology. These interviews can be found on the Mitesco website (https://www.mitescoinc.com/resources/media/ ) and the Company’s YouTube channel (https://youtu.be/wrYQOg8YD3g ). “As we grow, the number of inquiries from potential investors increases...

Johnson & Johnson partially converts its convertible loan

Written by Customer Service on October 27, 2021. Posted in Public Companies.

Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland – October 27, 2021Idorsia Ltd (SIX: IDIA) today announced that Cilag Holding AG, an indirect subsidiary of Johnson & Johnson, notified Idorsia that it will convert a second tranche of the remaining principal amount of CHF 445 million convertible loan, such that CHF 110 million will be converted into 9.6 million shares of Idorsia. As a result of the conversion, Idorsia will issue 9’581’882 new shares and Idorsia share capital will increase from CHF 8’364’748.55 to CHF 8’843’842.65, divided into 176’876’853 Idorsia shares. As a result of conversion of the second tranche of the convertible loan, Cilag Holding AG will hold 5.7% of Idorsia’s issued share capital. Following conversion, the remaining principal amount of the convertible loan will be CHF 335 million, convertible...

Day: October 27, 2021

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice